1. Home
  2. PLSE vs ULCC Comparison

PLSE vs ULCC Comparison

Compare PLSE & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$20.91

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$4.03

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLSE
ULCC
Founded
2014
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
PLSE
ULCC
Price
$20.91
$4.03
Analyst Decision
Buy
Hold
Analyst Count
1
8
Target Price
$22.00
$5.21
AVG Volume (30 Days)
221.4K
5.5M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,724,000,000.00
Revenue This Year
$840.00
$23.76
Revenue Next Year
$287.54
$11.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.56
$3.02
52 Week High
$26.30
$6.66

Technical Indicators

Market Signals
Indicator
PLSE
ULCC
Relative Strength Index (RSI) 46.61 52.91
Support Level $17.32 $4.01
Resistance Level $23.89 $4.15
Average True Range (ATR) 1.39 0.34
MACD -0.22 -0.02
Stochastic Oscillator 31.39 37.13

Price Performance

Historical Comparison
PLSE
ULCC

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

Share on Social Networks: